Caspase 7 antibody (N-Term)
Quick Overview for Caspase 7 antibody (N-Term) (ABIN187518)
Target
See all Caspase 7 (CASP7) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- N-Term
-
Sterility
- 0.2 μm filtered
-
Immunogen
- Synthetic peptide corresponding to amino acids 1 to 11 of the human caspase-7 enzyme.
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Western Blot The optimal dilution for a specific application should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Mouse monoclonal antibody against human Caspase-7 (cysteine-requiring aspartate protease-7). Available in 100 ul vials at a concentration of 1 mg/ml (100ug) in PBS with 0.08% sodium azide. The antibody is 0.2 um sterile filtered.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
-
- Caspase 7 (CASP7) (Caspase 7, Apoptosis-Related Cysteine Peptidase (CASP7))
-
Alternative Name
- Caspase-7
-
Background
- Caspases are key effectors of programmed cell death. Caspase-7 along with caspase 3 and 6 form the group of effector caspases that are responsible for the cleavage of multiple substrates including the cytokeratins, PARP, alpha lodrin, NuMa and others. Caspase-7 is a 303 amino acid protein with high similarity to caspase-3. Caspase-7 is found in three variant forms. Granzyme B activates pro-caspase-7 to a form which can cleave PARP to its key fragment of about 85 kDa. Also, in vivo caspase-7 appears to be a better substrate for granzyme B than caspase-3. Pro-caspase-7 has been shown to exist as dimers or high order oligomers. Caspase-7 may be an important intracellular effector of granzyme B-medicated apoptosis and cytotoxic T-lymphocyte-induced cell killing in vivo.
-
Pathways
- Apoptosis, Caspase Cascade in Apoptosis, Positive Regulation of Endopeptidase Activity
Target
-